The N-CoR loss observed in H2170 cells could be blocked by Kaletra, a clinical grade HIV protease inhibitor and a documented inhibitor of growth of NSCLC cells (Fig. 1E) [22]. This evidence concerns the gene NCOR1 and non-small cell lung carcinoma.